No Picture
News

Viscient Biosciences Will Bioprint 3D Lung Tissue to Aid Pandemic Research, and Viscient Founder Calls for Pause in Organovo Merger Attempt

Viscient will turn its attention to 3D bioprinting lung tissue for infectivity research to assist global efforts to combat SARS-CoV-2, the novel coronavirus that causes COVID-19Organovo failed to receive a majority of stockholder votes in favor of its … […]

No Picture
News

Primmune Therapeutics Announces the Selection of PRTX007 as Its Clinical Development Candidate for COVID-19 and Oncology Indications

SAN DIEGO, March 31, 2020 /PRNewswire/ –?Primmune Therapeutics announced today that it has selected PRTX007 as its lead clinical development candidate for SARS-CoV-2 (the virus that causes COVID-19) and for oncology indications.

“PRTX007 is … […]

No Picture
News

Equillium Announces Common Stock Purchase Agreement for up to?$15 Million with Lincoln Park Capital

LA JOLLA, Calif., March 30, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today … […]

No Picture
News

Coping with Coronavirus Stress

The COVID-19 pandemic is stressful. Emotions are running high. We are all coming to terms with many aspects of the situation: risks to physical health posed by the virus, disruptions to daily routines, struggles to find solutio… […]

No Picture
News

Biocept Enters into Laboratory Services Agreement with Second California-Based Independent Physician Association

Contract with second IPA serving California expands patient access to Biocept’s Target Selector(TM) liquid biopsy testing for the management of patients diagnosed with cancer

SAN DIEGO, March 26, 2020 /PRNewswire/ –?Biocept, Inc.?(Nasdaq: BIOC), a l… […]

No Picture
News

Forge Enters Into Collaboration With Roche To Develop Novel Antibiotic To Treat Lung Infections

-Forge is eligible to receive $190.5M in total payments-

SAN DIEGO, March 25, 2020 /PRNewswire/ — Forge Therapeutics, Inc. (Forge) announced today that they have entered into a research collaboration and option agreement with Hoffmann-La Roche Ltd. … […]